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Abstract
Background/Purpose: The purpose of this paper is to critically examine the literature and
evidence that is available surrounding pre-pregnancy and prenatal use of marijuana and the
effects it has on the developing fetus/infant.
Theoretical Framework: The Modeling and Role-Modeling Theory created by Erickson,
Tomlin, and Swain will be the theoretical framework used for this paper. The modeling aspect
of this theory speaks to a person developing a picture and perception of another person’s world.
The person develops this picture by viewing the other person’s framework, points of view,
values, experiences and perspectives.
Methods: Twenty research articles were found and critically reviewed to determine if there are
adverse effects associated with marijuana use during pre-pregnancy, pregnancy, and postpartum.
Results/Findings: It was found that across most findings that further research needs to be done
on the use of marijuana prior to pregnancy, during pregnancy, and postpartum. It has also been
found that screening and counseling needs to be done and focused on prior to pregnancy and
during pregnancy and postpartum. Potential adverse effects in the fetus/infant associated with
marijuana use prior to pregnancy, during pregnancy, and postpartum included growth restriction,
low birth weight, small for gestational age, higher rates of spontaneous preterm birth, increased
risk of neonatal morbidity, placental abruption, increased NICU admissions, stillbirth, and
anencephaly.
Implications for Research and Practice: Healthcare professionals have the opportunity to
establish a trusting relationship with their patients and to be able to effectively educate and
counsel their patients regarding the use of marijuana prior to pregnancy, during pregnancy, and
postpartum.
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Chapter I: Introduction
It is not hard to determine that marijuana use in the United States has skyrocketed in the
past two decades. This is due in large part to the medical legalization of marijuana and the most
recent legalization of it for recreational use in multiple states. There are currently 33 states along
with the District of Colombia that have legalized marijuana in some type of form, either for
medical use or recreational use (State marijuana laws, 2019).
Marijuana, sometimes referred to as cannabis, pot, hash, or Maryjane, has a history
tracing back 5000 years in Romania (Bridgeman & Abazia, 2017). Marijuana contains a mindaltering substance called delta-9-tetrahydrocannabinol, often referred to as THC. Marijuana is
the most commonly used illicit drug worldwide. Marijuana is typically taken one of three ways:
Inhalation via smoking, inhalation via vaporization, or through consumption of an edible product
containing THC. Marijuana is a Schedule 1 controlled substance that has limited medicinal use
and has a high risk for potential abuse and dependence. There is also a national concern that it is
a gateway drug to more dangerous substances (Bridgeman & Abazia, 2017).
Medical marijuana as a therapy has been the dominant topic of conversation in the last
few years. There are legal, ethical, and societal issues associated with its use for medicinal
purposes (Bridgeman & Abazia, 2017). Concerns include safe packaging, proper administration,
dispensing, and the adverse consequences that come along with its use. The Food and Drug
Administration (FDA) has said that it needs to investigate the claims that medicinal marijuana is
beneficial; research is ongoing regarding this (Bridgeman & Abazia, 2017).
Marijuana use in pregnancy has increased dramatically since its legalization for
medicinal and recreational purposes (Stickrath, 2019). Marijuana is currently the most
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commonly used illicit substance in pregnancy. That stems from the increasing use across all
populations due its legalization both medicinally and recreationally. It has been found that 3.9%
of pregnant women have used marijuana in the past month (1 or more times) and 7% of pregnant
women have used in the past year. Pregnancy is a time of extreme anatomical and physiological
changes in the woman (Soma-Pillay, Nelson-Piercy, Tolppanen, & Mebazaa, 2016). The
anatomical and physiological changes help to nurture and grow a developing fetus inside the
mother’s body. Conception to birth has a wide array of changes and they are all important to
growing a healthy fetus inside the womb. This is an extremely vulnerable part of a fetus’s
journey; without a mother taking care of her body with adequate nutrition and lifestyle factors,
there is risk to the fetus (Soma-Pillay et al., 2016).
These numbers all come from self-report, therefore the likelihood of the numbers being
higher is probable. The legalization of marijuana for medicinal and recreational purposes has led
to the general population’s decreased perception of the risks associated with its use. Findings
show that since the legalization of marijuana, THC has increased in marijuana from 4% in 1995
to 12% in 2019. There is a recommendation that all women be screened for marijuana use in
pregnancy and if they are found to have a positive drug screen, they should be encouraged to
discontinue use (Stickrath, 2019).
The concerns regarding marijuana use during pregnancy are related to the development of
the fetus in utero and the long-term effects associated with marijuana use. It is known that THC
crosses the placenta and reaches the fetus (Stickrath, 2019). The data on marijuana use has
focused on growth restriction, stillbirth, congenital anomalies, and neurodevelopmental effects
on the developing fetus. This data comes from self-reported use and there are usually other
factors, such as tobacco use, which can make the data difficult to interpret (Stickrath, 2019).
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Statement of Purpose
The purpose of this paper is to critically examine the literature that is available on
marijuana use in pre-pregnancy and pregnancy and determine if there are adverse effects on the
fetus/infant. It will examine the effects of marijuana use in women, on preterm birth,
breastfeeding, cognitive deficits, and neurodevelopmental delays in children later in life. The
Modeling and Role-Modeling theory will be examined and applied to the topic. The modeling
aspect of this theory speaks to a person developing a picture and perception of another person’s
world. The person develops this picture by viewing the other person’s framework, points of
view, values, experiences, and perspectives (Nouri, Ebadi, Alhani, & Rejeh, 2014).
Evidence Demonstrating Need
Marijuana is one of the most widely used substances during pregnancy. Marijuana use is
also increasing in mothers who breastfeed. There has been emerging data regarding the ability of
THC to cross the placenta, affecting development of the fetus (Grant, Petroff, Isoherranen, Stella,
& Burbacher, 2018). There has been widespread social media use recommending marijuana for
severe nausea during pregnancy. There is little information available to the general public about
the effects of marijuana use during pregnancy on the growing fetus.
In 2017 the American College of Obstetricians and Gynecologists (ACOG)
recommended that all women before pregnancy and in early pregnancy be questioned about their
use of tobacco, alcohol, and drugs including marijuana (ACOG, 2017). If women report use of
marijuana, they should be counseled about the potential adverse health consequences during
pregnancy. Women who are pregnant or who are thinking about pregnancy should be encouraged
to discontinue marijuana use. Women who are using marijuana for medicinal purposes during
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pregnancy should be counseled to select a different therapy that has better data available on its
use. ACOG also recommends discouraging the use of marijuana during breastfeeding due to
insufficient data available on the effects of the marijuana on the infant (ACOG, 2017).
“The Association of Women’s Health, Obstetric, and Neonatal Nurses (AHWONN)
(2018) supports the implementation of legislation, policies, and public health initiatives
that help raise awareness, remove stigma, discourage use, and facilitate access to prenatal
and maternity care for women who use marijuana during pregnancy.” AWHONN also
supports ongoing research of the short- and long-term effects for the woman, fetus, and
newborn (AWHONN, 2018).
Significance to Nurse-Midwifery
Nurse-midwives practice as primary health care providers for women and newborns up to
the age of 28 days. As described in the American College of Nurse-Midwives (ACNM)
Hallmarks of Midwifery, nurse-midwives care for women and assist with health promotion,
disease prevention, and health education (ACNM, 2012). Nurse-midwives also incorporate
scientific evidence into clinical practice and provide skillful communication, guidance, and
counseling to their patients. Nurse-midwives also seek to empower women as partners in health
care (ACNM, 2012).
Nurse-midwifery practice encompasses a holistic overview of a woman’s life. As
compassionate care providers, the possibility of having lifelong relationships with women in
healthcare is an advantage of having the potential to influence a woman’s decisions about her
healthcare in a positive way. Nurse-midwives can counsel a woman who uses marijuana either
pre-pregnancy or prenatally to influence her decision on whether to quit using marijuana. This
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can have lifelong implications not only for the woman using the marijuana but also for the babies
she goes on to deliver.
Theoretical Framework
Erickson, Tomlin, and Swain developed the Modeling and Role-Modeling Theory in
1982 (Nouri, Ebadi, Alhani, & Rejeh, 2014). The modeling aspect of this theory speaks to a
person developing a picture and perception of another person’s world. The person develops this
picture by viewing the other person’s framework, points of view, values, experiences, and
perspectives (Nouri, Ebadi, Alhani, & Rejeh, 2014). Role-modeling involves how the person
who is caring for the patient cares for and nurtures the patient to attain, maintain, and promote
health (Modeling and role-modeling, 2016). Role-modeling accepts the patient as they are and
then works the best way possible to come up with unique interventions characteristic to that
person’s personality. The patient is typically the expert in his or her care and usually knows what
is best for themselves (Modeling and role-modeling, 2016).
The theory of modeling and role-modeling explains how nurses provide care based on the
individualized person and the way that particular person views the world (Koren &
Papamiditriou, 2013). It is basically like trying to see the world through the patient’s eyes. It is
important to develop a trustworthy relationship with the patient in order to have any kind of
influence in the patient’s life (Koren & Papamiditriou, 2013).
As nurse-midwives, developing a rapport with patients is of the utmost importance. If a
visit for a patient who admits to smoking marijuana starts with the nurse-midwife instructing her
to stop and listing the affiliated ramifications, it may not go over well. Instead, if a rapport is
built first and it is in a nonjudgmental way, there is a much higher chance of being able to
persuade the woman to not smoke marijuana. Meeting the patient where she is and trying to
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figure out why she is smoking marijuana is also a key factor in determining the plan of action. If
the patient is smoking marijuana due to stress, then a nurse-midwife should help her figure out
where the stress is coming from and consider other interventions that are healthier and safer for
the mom, and if she is pregnant, her baby. By seeking to find the patient’s perspectives and
viewpoints, the next move is to role-model for the patient the best care for both mother and baby.
This can only be done if there is a level of trust and commitment from the provider to the
patient’s perspective.
Attributes of a role model that can contribute to the person’s perception of the role model
include similarities between the two, levels of success for the role model, and the role aspirant’s
belief of whether or not abilities are fixed or changeable (Morgenroth, Ryan, & Peters, 2015).
Healthcare practitioners must remember that their patients are watching their every move. If
patients can see the healthcare provider as successful and relatable, they are much more likely to
listen and take to heart when the recommendation is to not smoke marijuana.
Summary
The use of marijuana has increased in the past two decades due in large part of its
legalization both medicinally and recreationally. The number of pregnant women using
marijuana has also increased and women that are using marijuana while pregnant have a
decreased perception of the harmful effects of marijuana because it is legalized in many states.
The data on potential adverse effects on the fetus during pregnancy from the use of marijuana is
limited but the recommendation is to discontinue use in pregnancy if a positive drug screen
comes up in the lab work. Nurse-midwives have a unique opportunity to positively influence the
women they come into contact with and help them achieve the best outcomes prenatally and for
their infants postpartum.
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Chapter II: Methods
This chapter will clearly explain the process used to obtain and review the literature
related to marijuana use during pre-pregnancy, pregnancy, and postpartum and whether there are
any effects on the fetus/infant. It will include the criteria used for inclusion, exclusion, and a
summary of the studies that were selected. The studies found were analyzed for setting, study
sample, results, conclusions, and relevance to the topic according to the Matrix method by
Garrard (2017). The studies were also analyzed for different articles in the references section to
obtain more information. The level and quality of evidence were also reviewed and ultimately 20
articles were selected.
Search Strategies
The critical review of the literature was done across multiple databases including
CINAHL, PubMed, and Google Scholar. The key search terms used included “marijuana, ”
“cannabis,” “pregnancy,” “women,” and “effects on fetus/infant”. A CINAHL search using the
words “marijuana,” “women,” and “pregnancy” provided a search result of 36 articles. A
CINAHL search using the words “cannabis,” “pregnancy,” and “effects on fetus” provided a
search result of 15 articles. A PubMed search using the words “marijuana,” “effects,” and
“pregnancy” provided a search result of 277 articles. A snowball technique was also used in
relevant research articles to obtain additional literature to review.
Criteria for Inclusion and Exclusion
The selected articles for this review of the literature were included based on whether or
not the results from marijuana use showed impact or effects on the fetus or infant. These effects
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included preterm birth, congenital defects, developmental issues later in life, fetal development
including brain development, small for gestational age, and stillbirth. The criteria for dating the
articles included sources published from 2009 to the present.
Exclusion criteria included all studies conducted before 2009. Articles that were poor in
quality, according to the John Hopkins method of research, were also excluded. The research
database for marijuana use was limited due to minimal research on the subject; therefore, there
was not a lot of exclusion criteria implemented.
Summary of Selected Studies
The relevant studies found in the search process yielded a total of 328 potential articles.
Upon reviewing the possibilities, there were 20 studies included in this review of the literature.
The studies included retrospective cohort studies, case-controlled studies, secondary analysis
studies, experimental studies, longitudinal studies, cross-sectional studies, and non-experimental
studies. Most of the research was conducted in the United States with some being done in
Canada, Australia, New Zealand, Ireland, and the United Kingdom. No randomized control trials
were found in this search.
Evaluation Criteria
The articles in this review were analyzed using the Johns Hopkins Research Evidence
Appraisal Tool (Dang & Dearholt, 2018). Using this tool created the opportunity to grade the
level of evidence on a scale of I-IV. Level I studies include experimental studies, randomized
controlled trials (RCTs), explanatory mixed-method designs that include only a level I
quantitative study, and systematic reviews of RCTs with or without meta-analysis. Level II
studies include quasi-experimental studies, explanatory mixed-method design with only level II
quantitative studies, systematic reviews of a combination of RCTs, and quasi-experimental
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studies with or without meta-analysis. Level III studies include nonexperimental studies,
systematic reviews of a combination of RCTs, quasi-experimental and nonexperimental studies,
non-experimental studies with or without meta-analysis, exploratory, convergent, or multiphasic
mixed-methods studies, explanatory mixed-method designs that include only a level III
quantitative, and qualitative study meta-synthesis. Level IV studies include opinions of respected
authorities, clinical practice guidelines, consensus panels, and position statements. Level V
studies are based on experiential and non-research evidence (Dang & Dearholt, 2018).
After deciding on the level of evidence of the study, the article was then critiqued to
determine the quality of evidence (Dang & Dearholt, 2018). The classifications include low,
good, or high. The articles were classified based on the quality of the sample size, if the
conclusions were definitive, if the results were consistent, and if the results were generalizable
(Dang & Dearholt, 2018). Many of the studies used in this literature review were level III
studies.
Summary
This literature review was completed over several months using CINAHL, PubMed, and
Google Scholar. Although the research on marijuana use during pregnancy is limited, there is
research available and ultimately 20 articles were chosen based on relatability and quality of
evidence. The analysis of the research was conducted using the Johns Hopkins Research
Evidence Appraisal Tool.
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Chapter III: Literature Review and Analysis
Synthesis of the Critical Review of the Literature
The data was synthesized in Appendix 1 of this paper and common themes were found
amongst the data. The level of evidence and quality of each research study was appraised using
the Johns Hopkins Research Evidence Appraisal Tool (Dang & Dearholt, 2018). The matrix
format included purpose, sample/setting, level of evidence, quality of evidence, design method
and instruments, results, conclusion, strengths, and limitations. The findings are displayed with
the level I study first, and then nineteen level III studies in alphabetical order. The purpose,
design, and synthesis of the information found in these studies will be presented in Chapter III.
Further Research Needed
A common theme in a few of the research articles reviewed was that more research needs
to be done because there were no concrete outcomes found. Examples of this theme are
described below.
Bertrand et al. (2018) found that women who breastfed used marijuana the most
frequently among illegal drugs. Fifty breastfeeding women who admitted to marijuana use
supplied breastmilk samples between 2014-2017. Participants recalled marijuana exposure up to
14 days before the breastmilk sample was collected. THC was measured and in two-thirds of the
breastmilk samples provided were found to be highly variable in concentration. One of the
limitations of this study is that the breastmilk samples were collected under various conditions.
This was the first study to calculate specific cannabinoid levels in human milk and the study was
conducted with a relatively large sample of mothers who provided a detailed and varied history
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of marijuana use. Bertrand et al. (2018) found that there is a need for further research related to
this subject.
Conner et al. (2015) performed a retrospective cohort study, the purpose of which, was to
determine whether marijuana use in pregnancy was related to risk factors and occurrence was
associated poor neonatal outcomes. All term pregnancies occurring over a four-year period at
Washington University, which is located in St. Louis Medical Center, that met criteria equaled
8,138 women. All women who tested positive for marijuana in a drug screen or admitted use
through self-report were included. Neonatal morbidity was found in 11.6% of women who used
marijuana compared with 8% of women who did not use marijuana. After adjusting for
confounding variables, there was not a significant difference in neonatal morbidity for women
who used marijuana and those who did not. Further research is needed to determine the amount
and extent of marijuana use and the relationship to adverse neonatal outcomes (Connor et al.,
2015).
Mark et al. (2015) conducted a retrospective cohort study on a University-based prenatal
care clinic from July 2009 to June 2010. They were looking at primary exposure of marijuana
use that was defined by either self-report or urine toxicology. Marijuana use was not found to be
related to low birth weight (13.8% vs 14.0%, p=1.00), preterm delivery (17.7% vs 12.0%,
p=0.325), or NICU admissions (25.5% vs. 15.8%, p=0.139). Study results also showed that
prenatal care utilization was equal between the two groups of marijuana users and non-users. The
authors concluded that marijuana use in early pregnancy is common, but it is also common for
moms to stop smoking marijuana by the time of delivery. As marijuana use increases in
pregnancy, larger prospective trials are warranted in order to determine the impact of different

20
levels of marijuana use on birth outcomes and long-term neurological developments in infants
(Mark et al., 2015).
Roberson et al. (2014) conducted a study with secondary analysis on data from the
Pregnancy Risk Assessment Monitoring System (PRAMS) from Hawaii from 2009-2011. They
found that 6.0% (95% CI: 5.2-6.8 ) of women reported marijuana use in the month before their
most recent pregnancy and 2.6% (95% CI: 2.2-3.2) reported using marijuana during their most
recent pregnancy. Approximately 21.2% of women with live births in Hawaii where this study
was done developed severe nausea during their most recent pregnancy. Women who reported
severe nausea during pregnancy were more likely to report marijuana use during pregnancy
(3.7% vs. 2.3%; PR=1.63, 95% CI: 1.08-2.44) than those women who did not have severe nausea
during the course of their pregnancy. The association of marijuana use for severe nausea was
statistically significant (p=0.034). The findings of this study indicate women use marijuana as an
anti-emetic for severe morning sickness. Additionally, marijuana use before pregnancy has been
found to be associated with an increased likelihood of severe nausea during pregnancy. A
limitation of this study is that as a single site study, it may not be generalizable to other regions
of the country. These preliminary findings warrant further research being done on cannabinoid
hyperemesis syndrome. This is an increasingly documented phenomenon in pregnant women
who use marijuana prior to pregnancy (Roberson et al., 2014).
Screening and Counseling
A common theme found in many of the articles is that screening for marijuana use needs
to be done in women before pregnancy and early on in their prenatal visits. Additionally,
extensive counseling needs to be done with women who admit to marijuana use or who show up
positive on drug screening tests done routinely prenatally in the first trimester.
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Chabarria et al. (2016) conducted a retrospective cohort case study design that included
12,069 subjects who were able to provide information regarding their marijuana use and
pregnancy outcomes. In the initial cohort analysis, marijuana exposure during pregnancy was not
associated with significant perinatal adverse outcomes; however, it was found that concurrent
use with cigarettes increased risk over either factor alone. Preterm birth was significantly higher
in women reporting cigarette use as well as both cigarette use and marijuana use. Chabarria et al.
(2016) found that it is important to counsel patients about the use of cigarettes and marijuana in
pregnancy due to the high number of women who use both concurrently.
Martin et al., (2015) conducted a data analysis study using information that was obtained
from the Treatment Episodes Data Set from the years 1992-2012 and analyzed the data over time
using Chi Square, Cochran-Armitage, and Moran's I tests. The objective was to investigate
recent trends in marijuana use during pregnancy in the United States. They found that the
number of pregnant women who had treatment admissions remained fairly stable at 4%. They
found that marijuana use has increased from 29% to 43% (p<0.01) during these years. They
concluded that even though more women using marijuana are seeking treatment during
pregnancy, health care providers, specifically prenatal caregivers, should be targeting certain atrisk groups and improving screening and treatment referrals for marijuana use during pregnancy.
The strength of this study was that it had a well-balanced cohort across multiple covariates
including maternal age, socioeconomic status, and tobacco smoking (Martin et al., 2015).
Ko et al., (2015) conducted a study to obtain national prevalence, patterns, and correlates
of marijuana use in the past month and also in the past 2-12 months amongst women of
reproductive age by pregnancy status. It was found that 3.9% (95% CI, 3.2-4.7)
of pregnant women in this study used marijuana in the past month and 7.0% (95% CI, 6.0–8.2)
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of pregnant women had used in the past 2-12 months. Among those pregnant women who
admitted to marijuana use in the past year, 16.2% used marijuana daily. It was found that 18.1%
of pregnant women who used marijuana met the criteria for abuse and/or dependence. The
authors concluded that healthcare providers should be aware of marijuana use amongst their
patients and should be able to provide the proper resources necessary to their patients who are
using marijuana. Medical and recreational marijuana use is being legalized in states and there
needs to be further research done on the potential adverse effects of marijuana use in pregnancy
(Ko et al., 2015).
De Genna et al. (2015) conducted a prospective study that examined 456 pregnant
women ranging in age from 13 to 42 years. These women were asked about their cannabis use
one year prior to pregnancy, in each of their trimesters of pregnancy, and at 6, 10, 14, and 16
years postpartum. A growth mixture model (GMM) was used to explore different trajectories of
use over time. The GMM indicated four patterns of maternal cannabis use over time. These are
best described as non/unlikely to use at any time point which accounted for 61%, late desistance
(no use during pregnancy but reported use 6 and 10 years postpartum) which accounted for 15%,
decreasing likelihood of use meaning used in the year prior to pregnancy and then with a steady
decline in use over the postpartum period which accounted for 11%, and increasing
likelihood/chronic users which accounted for 14%. The results of the study showed that younger
mothers are more likely to use cannabis across 17 years. These findings have important benefits
for both the prevention and treatment of cannabis use in mothers (De Genna et al., 2015). This
can guide healthcare professionals to tailor their screening, counseling and education based on
these findings to decrease marijuana use during pregnancy.

23
Day et al. (2006) conducted a study to determine the effects of prenatal marijuana
exposure based on the age of onset of use and frequency of use amongst 14-year-olds whose
mothers used marijuana prenatally. The sample for this study was taken from women aged 18-42
who were receiving care in a prenatal clinic that was based out of a hospital. There were 563
(mother and daughter) pairs included in this study. Most of the participants qualified as light to
moderate marijuana users during pregnancy. The study showed that prenatal marijuana exposure
predicted the start and frequency of marijuana use amongst 14-year-old children even when all
other variables were considered. It was also found that mothers who had depression were more
likely to have children who start using marijuana at an early age. Current maternal tobacco use
was also significantly associated with the frequency of adolescent marijuana use. The conclusion
was that prenatal exposure to marijuana, along with other factors, has a significant association
with marijuana use at age 14. A strength of this study was that the women were followed
throughout pregnancy and multiple times throughout childhood and there was an adequate
number of women who participated in this study. One limitation of the study is that it was mostly
done in women from lower socioeconomic status, making it less generalizable to the public (Day
et al., 2006). The results from this study can show parents that exposure prenatally to marijuana
might predict the use of marijuana in their children and this is an important message to counsel
patients about.
Oh et al. (2017) conducted a study to examine correlations between prenatal marijuana
use and the effects of marijuana-specific risk/protective influences on marijuana use trends. The
study was done using data taken from the National Survey on Drug Use. There were 7627 female
respondents aged 18-44 included in the sample. The effect of marijuana use was analyzed using
logistic regression analysis while adjusting for complex sampling design effects and controlled
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for sociodemographic and marijuana-specific factors. Data utilized came from the years 20052014. During this period unmarried pregnant women’s incidence of marijuana usage increased
by 85%, whereas married pregnant women’s marijuana use remained steady. The authors
concluded that preventative efforts should be made with unmarried pregnant women and
education and counseling should be given about the potentially harmful effects of marijuana
smoking on maternal and child health. Education of all pregnant women about the effects of
marijuana should be done and especially for unmarried pregnant women. Findings also suggest
that emphasis should be placed on providing attention to unmarried pregnant women’s mental
health issues along with their associated health-risk behaviors (Oh et al., 2017).
Adverse Effects
There is a general consensus that more research is needed to determine how marijuana
use during pregnancy could impact the health and development of infants. The research is
needed due to changing regulations on marijuana, increased access to marijuana for pregnant
women, as well as an increasing number of pregnant women who are using marijuana in the past
decade. There are only a few studies that have done that have found associations between
marijuana use in pregnancy and adverse effects on the infant/fetus.
The longitudinal study by Carter et al. (2016) was the first human study to show distinct
patterns of pathology with multiple substance use. This study examined the effects of prenatal
alcohol, methamphetamine and marijuana exposure on infant development. These mothers were
recruited from birthing units that mainly served the economically disadvantaged. The final
sample included 103 placentas from mothers who had multiple substance use and were examined
by a senior placenta pathologist. This study showed that women who used marijuana also
participated in poly-substance abuse. Other results from this study were associated with
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increased placental weight which suggests different components for the damage caused by the
exposure. These results are important as the placenta serves as the vital regulator of the
intrauterine environment, and increased placenta growth could be a direct response of chronic
hypoxia from marijuana use (Carter et al., 2016).
The goal of the study by Warshak et al. (2015) was to analyze a group of 6,648 women to
determine if there are associations between marijuana use in pregnancy and adverse effects in the
mom and baby. A retrospective cohort study of all deliveries of single babies that were born over
20 weeks’ gestation was completed at a large university hospital. Logistic regression was then
performed to evaluate their goal. There were 14 outcomes examined using a significant P-value
of 0.004. This study did not find any adverse outcomes with marijuana use and preterm birth
(p=0.15), pre-eclampsia (p=0.12), stillbirth (p=0.54), or unplanned cesarean section (p=0.75).
Marijuana use was significantly correlated with higher rates of small for gestational age babies
(p=0.001). The authors also found a trend towards marijuana users and higher rates of NICU
admissions and perinatal mortality, but they were not statistically significant (p= 0.01 & p=0.14).
Much like the Warshak et al. (2015) study, the study by Corsi et al. (2019), showed there
was evidence to support the correlation between cannabis use and an increased risk of preterm
birth. This study was also a retrospective cohort analysis that included women 15 years of age or
greater who delivered at a gestational age of 20 weeks or greater. Women who self-reported use
of cannabis during pregnancy were compared with women who did not report use: this was done
using standardized mean differences (SMD); SMD greater than 10% were considered suggestive
of a meaningful difference across the two groups (Corsi et al., 2019). The results of this study
showed an increase in preterm delivery in the cannabis-using group. The preterm risk difference
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(RD) was 5.88%. There was also a relationship between cannabis use and small for gestational
age infants (Corsi et al., 2019).
The study by van Gelder et al. (2009) analyzed data from a case study from the National
Birth Defects Prevention Study. The goal of the study was to determine if there were positive
associations between periconceptional illicit drug use and 20 different birth defects categories.
This study found marijuana to be the most frequently reported illicit drug. Cannabis use was
associated with an increased risk of anencephaly (OR=1.7/CI=0.9-3.4). This study did not find
any other associations between periconceptional cannabis use and other congenital
malformations (Gelder et al., 2009).
The Stillbirth Collaborative Research Network of the Eunice Kennedy Shriver National
Institute of Child Health and Human Development with Varner et al. (2014) conducted a study
on the effect of smoking and other illicit drug use on stillbirth. Comprehensive standardized fetal
postmortem examination was done by several perinatal pathologists. The results showed that
women who experienced a stillbirth were twice as likely to report addiction to an illicit drug. The
most common drug detected was tetrahydrocannabinol acid which was significantly associated
with stillbirth (OR 2.34, 95%, CI 1.13-4.81). Cannabis use increased the odds of stillbirth
twofold per this study (Varner et al., 2014).
The secondary analysis from the Stillbirth Collaborative Research Network of the Eunice
Kennedy Shriver National Institute of Child Health and Human Development by Metz et al.
(2017) examined marijuana use and any adverse pregnancy or neonatal morbidity outcomes. The
adverse pregnancy outcomes were small for gestational age babies, hypertension, and preterm
birth. Neonatal morbidity outcomes included neonatal intensive care unit (NICU) admission and
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other conditions that would cause a NICU admission. There were no associations with adverse
pregnancy outcomes (Metz et al., 2017).
In the study by Benevenuto et al. (2016) there was an investigation of the effects of
inhaled cannabis in mice. Twenty healthy female mice were divided into two groups of 10 each.
The mice in the cannabis group were exposed daily for 5 minutes to marijuana smoke. Urine was
then collected every 24 hours after exposure. Half of the dams were euthanized, their fetuses and
placentas were removed, weighed and checked for malformations. The other half of the mice
were delivered naturally and monitored. The statistical significance was set at p<0.05. The
results showed that fetal weight was significantly lower in the pups delivered from the cannabis
smoke group (p=0.02), the placental weight was greatly increased in this group as well (p=0.04).
These results show that smoking marijuana during pregnancy, even in low doses can be fatal to
the embryo and fetus (Benevenuto et al., 2016).
Marroun et al. (2009) performed a multiethnic population-based prospective cohort study
using information from the Generation R study. They explored the timing and frequency of
substance use with measures using self-report. A total of 7452 mothers participated in this study
to determine if cannabis use has affects fetal growth. Of the women who reported cannabis use
during pregnancy, 85% of those mothers also smoked tobacco. The results of this study indicated
that continued cannabis use during pregnancy showed growth reduction of p=.052 in midpregnancy with a reduction of 277 g at birth (p=.001). Another finding of significance was a
smaller head circumference of -0.21 mm/week (p=.001). Decreases in fetal growth and head
circumferences are known risk factors for neurodevelopment and behavioral problems. This
study also suggested a dose-response association: Heavier cannabis use during pregnancy is
correlated with lower birth weight (Marroun et al., 2009).
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Crume et al. (2018) performed a cross-sectional study using population-based data
regarding cannabis use during and after pregnancy from a random sample of 3207 women who
delivered a live born infant between January 1, 2014, and December 31, 2015. They sought to
look at the relationship between maternal cannabis use at any time during pregnancy and adverse
neonatal outcomes such as low birth weight, small for gestational age, NICU admission, and
preterm birth. They found the overall rate of cannabis use at any time during pregnancy was
5.7% (95% CI). Any cannabis during any time of pregnancy was correlated with an 80%
increased likelihood of an infant with low birth weight (OR, 1.8; 95% CI, 1.3-2.4; p = .0008). A
strength of this study is that it used the Pregnancy Risk Assessment Monitoring System
(PRAMS), which is the largest state-based surveillance program of pregnant women and live
births in Colorado. A limitation of this study was self-reported maternal cannabis, which could
result in inaccurate information. The study found that maternal cannabis use at any time during
pregnancy was associated with a 50% increased likelihood of low birth weight, independent of
other factors including tobacco use during pregnancy. This information highlights the importance
of healthcare providers screening for cannabis use during pregnancy and the need for counseling
about the adverse health effects of continued use during pregnancy postpartum including during
lactation (Crume et al., 2018).
Data from the analysis by Leemaqz et al. (2016) was obtained from the Screening for
Pregnancy Endpoints (SCOPE) study. Data from the 5,588 participants was included to examine
the association of maternal marijuana use with pregnancy outcomes. Results showed that
concurrent use of cigarettes and marijuana at 20 weeks’ gestation was associated with small for
gestation age (p=0.001), and spontaneous preterm birth (SPTB) (p=0.001). Breslow Day testing
showed there was no difference in the results between marijuana and tobacco smokers versus
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marijuana use only (p=0.238). The Mantel-Haenszel test showed the association between
marijuana use and SPTB was independent of the smoking status, with adjusted common odds of
2.28. Based on this finding it is likely that maternal marijuana use is an independent risk factor
for SPTB (Leemaqz et al., 2016).
Synthesis of the Major Findings
Several themes were identified in the 20 scholarly articles in this review among women
who used marijuana pre-pregnancy and prenatally. A common theme included that more
research was needed to draw definitive conclusions, and screening and counseling needed to be
done among pre-pregnant and pregnant patients. There were adverse effects associated with
marijuana use in pregnancy that included growth restriction in the neonate, low birth weight,
small for gestational age, spontaneous preterm birth, increased risk of neonatal morbidity,
placental abruption, increased NICU admissions, stillbirth, and anencephaly.
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Chapter IV: Discussion, Implications, and Conclusions
The purpose of the critical review of this literature was to determine if adverse effects on
the fetus/infant occur as a result of marijuana use in the mother pre-pregnancy, during
pregnancy, and postpartum. For this review, twenty research articles were used; each was
pertinent to the question being asked. The articles were reviewed using the John Hopkins
Research Evidence Appraisal Tool. After the critical review of the literature was done the
implications for nurse-midwifery were obtained and the limitations were also identified. Chapter
IV will discuss the implications for nurse-midwifery along with the opportunities for further
research that can be done. The chapter will conclude with the integration of Modeling and RoleModeling Theory into nurse-midwifery practice and how to apply it to women who are using
marijuana pre-pregnancy, during pregnancy, and postpartum.
Literature Synthesis
The research question posed for the critical review of the literature was to find out
whether marijuana use in women pre-pregnancy, during pregnancy, or postpartum had any effect
on the fetus/infant of that mother. Research regarding marijuana use is not complete as this is a
new area of research, due to its legalization both medicinally and recreationally. There was one
level I study found that was an animal study, and the remainder of the studies found were level
III studies. The critical review of the literature revealed the following themes: Further high-level
research needs to be done, screening and counseling of women using marijuana was necessary,
and that several adverse effects were associated with marijuana use. There was a significant
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overlap throughout the research articles that called for more research in order to obtain a stronger
correlation between marijuana use and adverse effects.

Current Trends and Gaps in the Literature
Further Research Needed Nursing related research surrounding marijuana use is new and has
not yet been able to reach statistically significant findings proving causality. Several authors
(Bertrand et al., 2018, Connor et al., 2015, Conner et al., 2015, Mark et al., 2015) conducted
research that found non-significant results. (See the Appendix 1 for findings and results).
Marijuana use has increased dramatically in the last two decades due in large part to its medical
and recreational legalization. This is going to be an issue that needs to be dealt with increasingly
as more and more mothers are turning to marijuana for ailments in pregnancy and recreational
use.
Screening and Counseling Screening for drug use needs to be done not only prenatally, but also
prior to pregnancy. This gives the provider an opportunity to offer counseling before pregnancy
happens in order to achieve the best and safest results possible related to pregnancy. With the
increasing use of marijuana comes the increasing need for screening and counseling among
women. This counseling needs to be extensive if a woman admits to marijuana use or shows up
positive on routine drug screens in pregnancy. (Chabarria et al., 2016, Martin et al., 2016, Ko et
al., 2015, DeGenna et al., 2015, Day et al., 2006, and Oh et al., 2017).
Adverse Effects Identified The number one thing that patients want to know when it comes to
marijuana use in pregnancy is whether the research is saying definitive adverse effects have been
identified. The consensus is that more research is needed to determine how marijuana use during
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pregnancy can affect the health and development of fetuses/infants. There are only a few studies
that show negative effects of marijuana use during pregnancy.
Carter et al. (2016) found that women who use marijuana during pregnancy were also
abusing other illicit substances during pregnancy. Increased placental weight was associated with
exposure to marijuana and other substances (Carter et al., 2016).
Warshak et al. (2015) found that marijuana use was significantly correlated with higher
rates of small for gestational age infants born (p=0.001). It was also found that marijuana use
was associated with higher rates of NICU admissions and perinatal mortality, but they were not
statistically significant (p=0.01 & p=0.14). Corsi et al. (2019) found a correlation between
cannabis use and an increased risk of preterm birth. They also found a relationship between
cannabis use and small for gestational age infants (Corsi et al., 2019). Marijuana was the most
commonly reported illicit drug and was associated with an increased risk of anencephaly (Gelder
et al., 2009).
Women who had a stillbirth were twice as likely to report addiction to an illicit drug and
the most common drug detected was THC as found in marijuana. The use of cannabis in
pregnancy increased the odds of stillbirth twofold per this study (Varner et al., 2014). Metz et al.
(2017) also found a correlation between marijuana use and small for gestational age infants,
preterm birth, and increased NICU admissions (Metz et al., 2017). Crume et al. (2018) concluded
that marijuana use during pregnancy was associated with an 80% increased likelihood of low
birth weight in infants born to those mothers (Crume et al., 2018).
Benevenuto et al. (2016) concluded that fetal weight was significantly lower in the mice
pups delivered from the group which had inhaled marijuana. It was also found that placental
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weight was significantly greater in this group as well. This study concluded that smoking
marijuana during pregnancy can be embryotoxic and fetotoxic (Benevenuto et al., 2016).
Marroun et al. (2009) showed that women who used marijuana during pregnancy had
babies born with growth reduction on average of 2277 grams at birth and smaller head
circumferences. These are significant findings because decreases in fetal growth and head
circumferences are known risk factors for neurodevelopment and behavioral problems later on in
life (Marroun et al., 2009). Leemaqz et al. (2016) found that marijuana use and cigarette smoking
at 20 weeks’ gestation was associated with small for gestational age infants and spontaneous
preterm birth. Marijuana use is likely an independent risk factor for spontaneous preterm birth
(Leemaqz et al., 2016).
Implications for Practice
As marijuana becomes increasingly popular across the United States, it means that
healthcare professionals need to take an active role in the screening, counseling, and education of
their patients. Mainstream media is going to tell the public what they want to hear, which will
typically be that there is no concrete evidence that marijuana in pregnancy causes birth defects or
adverse outcomes. The Core Competencies for Basic Midwifery Practice outline the Hallmarks
of Midwifery, which include incorporating scientific evidence into clinical practice and using
skillful communication, guidance, and counseling (ACNM, 2012). It is critical for healthcare
professionals who deal with the pregnant population to continue to stay up to date on the
research that is coming out. More research is being done on marijuana use in pregnancy; in the
next few years there will likely be more definitive answers relating to marijuana use in
pregnancy and the adverse effects associated with its use.
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It is well known that midwifery care boasts a different kind of care for women than the
typical physician practice. Midwives are known to spend ample time with their patients and to
develop long-lasting relationships with their patients. Midwives can use this to their advantage
by counseling patients that they know are using marijuana prior to pregnancy to help them to live
the healthiest life possible. If midwives can counsel their patients before pregnancy and help
them make decisions regarding cessation of marijuana use, it will prepare them to have the
healthiest pregnancy possible in the future. Having a trustworthy and respectful relationship with
a patient helps the patient trust the care provider, and the patient will also typically value the
opinions and education presented by the care provider. This is one of the most important
cornerstones of midwifery care.
Recommendations for Further Research
Throughout the research review process several areas were found that warrant further
research. These include the quantity and frequency of marijuana use and its effect on the
developing fetus/infant. There also needs to be more research allowing the possibility to look at
marijuana use in pregnancy without concurrent cigarette use. Some of the most important
research on marijuana use during pregnancy provides a glimpse into those groups of women at
higher risk for marijuana use in pregnancy. This offers the care provider a unique perspective
concerning who their high-risk patients are, and who they should be spending more time with
regarding the education and counseling aspect of discouraging the use of marijuana during
pregnancy and postpartum. There is an opportunity for further research in terms of how
education and counseling can be offered most effectively to these groups.
Due to marijuana’s legalization there will be an opportunity to have more studies with
women consenting to research on marijuana use during pregnancy as time goes on. Health care
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providers desire research that can help them effectively educate, counsel, and advise their
patients on marijuana use. In time, there will also be increasing numbers of women who have
previously used marijuana during pregnancy which will allow for increasing research to be done
on the long-term effects of marijuana use in pregnancy.
Integration of Modeling and Role-Modeling Theory
The Modeling and Role-Modeling Theory was developed in 1982 by Helen Erickson,
Evelyn Tomlin, and Mary Anne Swain (Nouri, Ebadi, Alhani, & Rejeh, 2014). The basis of this
theory speaks to a person developing a picture and perception of another person’s world. The
person develops this picture by viewing the other person’s framework, points of view, values,
experiences, and perspectives. The Modeling and Role-Modeling Theory offers a unique
perspective for care providers and the care they can provide to their patients.
By developing a trustworthy relationship with a patient, the care provider is allowed a
unique and intimate relationship. Building a rapport with a patient that is trustworthy, honest,
and caring allows for counseling and education on a level that the patient feels comfortable
accepting. A nurse-midwife who truly seeks to investigate the woman’s life and to determine
why she is doing something can help to tailor the education and counseling to be most effective.
The nurse-midwife can incorporate concepts of the Modeling and Role-Modeling theory to her
advantage to connect with patients on a level that they may not necessarily get in a busy
OB/GYN setting.
Conclusion
The pertinent findings of this critical review of the literature include adverse effects
related to prenatal marijuana use, the need for more research, and the need for screening and
counseling. Perhaps the most important of these is the need for extensive screening and
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counseling of women who are of childbearing age. The need for screening, guidance, and
education in women who are thinking about getting pregnant in the future is of the utmost
importance. By establishing early on that marijuana use during pregnancy and possibly
prepregnancy may have detrimental effects, care providers can give their patients and their
patients’ potential offspring the best possible chance at a healthy life.
Nurse-midwives are at a unique advantage with their patients due to the specific nature of
their role and their ability to develop lifelong relationships, fostering a true and lasting trust
between the two parties. Nurse-midwives follow the Hallmarks of Midwifery that speak to the
therapeutic value of human presence, skillful communication, guidance and counseling, and to
the empowerment of women as partners in healthcare (ACNM, 2012). This allows nursemidwives to truly empathize with the patient and allow her to be a part of her care and plan of
care. It is important that human beings remain autonomous in their healthcare decisions while
seeking care from a healthcare provider. It is also important that the nurse-midwife incorporate
scientific evidence into clinical practice (ACNM, 2012). The balance and art of midwifery
combine all these things into a beautiful display of compassionate care that is evidence-based.
This is truly a lifelong learning journey that gets better with time. The ability to support women
as nurse-midwives in a world where marijuana becomes increasingly legal and more prevalent is
an opportunity to create changes that will have ripple effects for lifetimes to come.
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Appendix 1: Matrix of the Literature
Source:
Benevenuto, S., Domenico, M., Martins, M., Costa, N., De Souza, A., Cista, J., Tavares, M.,
Dolhnikoff, M., & Veras, M. (2017). Recreational use of marijuana during pregnancy and
negative gestational and fetal outcomes: an experimental study in mice. Toxicology,376(1),
94-101. https://doi.org/10.1016/j.tox.2016.05.020
Purpose/Sample Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
20 pregnant mice were
Marijuana smoke
Strengths:
To
placed randomly into two inhalation
This exposure model
experimentally
groups, one exposed
negatively affected
has already proven
investigate the
(nose-only) daily for
the gestational and
successful, once it was
effects of
5 min to marijuana smoke fetal outcomes in
confirmed the presence
maternal
or filtered air in the
the mice. Five
of THC–COOH in
inhalation
control group. Mice were
minutes of daily
urine. Furthermore, it
of Cannabis
weighed daily during the
(low dose) exposure also proved to be a
sativa smoke
exposure period, and food during pregnancy
safe and not stressful
representing as
intake was recorded. On
resulted in reduced
method, causing no
nearly as
GD 18.5, half of the mice birth weight, and
deaths during the
possible
were euthanized, the
litter size was not
exposure process and
conditions of
abdominal wall was
altered; however,
no changes in feeding
human
immediately opened, and
the number of male behavior.
marijuana use in the uterus was examined
pups per litter was
terms of dose
carefully. The fetuses and higher. Besides,
and use to
placentas were removed,
placental wet
Limitations:
evaluate the
checked for
weight was
The small volume of
effects on
malformations, and
increased, and fetal- urine that was
gestational and
weighed. The other half of to-placental weight collected after the
fetal outcomes.
pregnant mice delivered
ratio was decreased exposures, and the
naturally, and they were
in male fetuses,
low-dose exposure that
Sample/Setting: continuously monitored in showing a sexwas adopted in this
20 female mice
order to verify whether the specific effect.
study, imposed many
age 60 days, and offspring born were dead
difficulties to
3 male mice, age or alive
determinate its
80 days with
quantities in this
proven fertility.
biological matrix.

Level of
evidence:
I

Conclusion:
The results indicate
that smoking
marijuana during
pregnancy even at
low doses can be
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Quality of
evidence:
High

embryotoxic and
fetotoxic, increasing
implantation
failures and
compromising fetal
development.

Author Recommendations:
More studies are needed to recognize and better understand the impacts of smoking marijuana
during pregnancy and its impacts on future health.
Summary for current clinical practice question:
With more and more legalization of recreational use of Cannabis, there is an urgent need of
further toxicological studies to better recognize the effects and explain the mechanism
involved with Cannabis use in pregnancy.
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Source:
Bertrand, K., Hanan, N., Honerkamp-Smith, G., Best, B., & Chambers, C. (2018). Marijuana
use by breastfeeding mothers and cannabinoid concentrations in breast milk. Pediatrics, 142,
(3), 1-8. DOI: 10.1542/peds.2018-1076
Purpose/Sample Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Volunteers residing in
∆9-THC was
Strengths:
To quantify
the United States and
measurable in highly
This is the first study
cannabinoids in
Canada have been
variable
used to calculate levels
concentrations in the
of specific
human milk after
recruited into the
maternal
University of
breast milk of
cannabinoids
approximately twodetectable in human
marijuana use.
California, San Diego
Mommy’s Milk, the
thirds of samples
milk in a relatively
human milk
from women who
large sample of
reported marijuana
mothers with detailed
biorepository (HMB)
through a variety of
use during
and varied histories of
breastfeeding and up
recent marijuana use.
sources including
to 6 days since last
social media.
Sample/Setting:
Breastfeeding mothers reported dose.
50 breastfeeding
completed an interview
women who
providing
reported
demographics,
marijuana use
maternal and child
between 2014health history, and
2017.
details regarding
exposures to
medications, alcohol,
tobacco, and other
recreational substances.
Limitations:
Participants recalled
Samples were
their exposures for the
collected under
14 days before milk
different conditions,
Conclusion:
Johns Hopkins
sample collection.
Marijuana is the most not all breast milk
Evidence
commonly used
collections were
Appraisal:
recreational drug
directly observed, and
among breastfeeding
we relied on maternal
Strength:
women; information
report of marijuana
Level II
regarding risks to
exposure.
breastfeeding infants
Quality:
is urgently needed.
Good
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Author Recommendations:
There is a critical need for further research on neurodevelopmental outcomes in infants
breastfed by mothers using marijuana.
Summary for current clinical practice question:
Because the brain rapidly develops during the time period when, ideally, a child’s main source
of nutrition is human milk, brain development may be altered by marijuana exposure.

Source: Carter, R., Wainwright, H., Molteno, C., Georgieff, M., Dodge, N., Warton, F.,
Meintjes, E., Jacobson, J., & Jacobson, S. (2016), Alcohol, methamphetamine, and marijuana 47
exposure have distinct effects on the human placenta. Alcoholism: Clinical Experimental
Research, 40, 753-764. doi:10.1111/acer.13022
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Longitudinal study.
Alcohol exposure
Strengths:
To see what
The women in the
was related to
This is the ﬁrst human
eﬀects, if any, of
sample were recruited
decreased placental
study to show that
prenatal exposure between October 2011 weight and a smaller alcohol,
to
and October 2014 from placenta-tomethamphetamine, and
methamphetamine, 3 antenatal midwife
birthweight ratio. By marijuana were
marijuana, and
obstetric units that
contrast,
associated with distinct
cigarette smoking serve economically
methamphetamine
patterns of pathology,
on placental
disadvantaged Cape
was associated with
suggesting diﬀerent
development.
Colored communities
larger placental
mechanisms mediating
in Cape Town.
weight and a larger
their eﬀects on
Sixty-six heavy
placenta-toplacental development.
drinkers and 37
birthweight ratio.
nondrinkers were
Marijuana was also
interviewed about their associated with larger
Sample/Setting:
alcohol, cigarette
placental weight.
103 placentas
smoking, and drug use Alcohol exposure
from pregnant
at 3 antenatal visits. A was associated with
women recruited
senior pathologist,
increased risk of
at their first
blinded to exposure
placental
prenatal visit.
status, performed
hemorrhage. Prenatal
comprehensive
alcohol, drug, and
pathology
cigarette use were not
examinations on each
associated with
placenta using a
chorioamnionitis,
Limitations:
standardized protocol.
villitis, deciduitis, or Measurement error
In multivariable
maternal vascular
surrounding estimates
regression models,
under perfusion.
of true alcohol
Johns Hopkins
eﬀects of prenatal
Alcohol and cigarette exposure to the fetus
Evidence
exposure were
smoking were
may obscure some
Appraisal:
examined on placental associated with a
group diﬀerences.
size, structure, and
decreased risk of
Given that urine
Strength:
presence of infections
intrauterine passing
testing was not
and meconium.
of meconium, a sign
available for all
Level II
of acute fetal stress
women reporting
and/or hypoxia;
methamphetamine use,
Quality:
methamphetamine,
we could not separate
with an increased
eﬀects of
Good
risk.
methamphetamine on
the placenta from
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potential eﬀects of
methaqualone.

Conclusion:
Given the growing
body of evidence
linking placental
abnormalities to
neurodevelopmental
deﬁcits, these
ﬁndings may be
important in the longterm teratogenic
eﬀects of prenatal
alcohol and drug
exposure.

Author Recommendations:
Future studies are needed to examine the eﬀects of growth restriction on growth and
neurodevelopment and the long-term developmental consequences of the exposure-related
placental abnormalities for the child.
Summary for current clinical practice question:
Increased placental growth may occur in response to chronic hypoxia caused by marijuana.
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Source: Chabarria, K. C., Racusin, D. A., Antony, K. M., Kahr, M., Suter, M. A.,
Mastrobattista, J. M., & Aagaard, K. M. (2016). Marijuana use and its effects on pregnancy.
American Journal of Obstetrics and Gynecology, 215(4), 1-6.
https://doi.org/10.1016/j.ajog.2016.05.044
Purpose/Sample

Design
(Method/Instruments)
Purpose:
Design:
The primary aim
This was a
of this study was
retrospective cohort
to examine both
study design that
maternal and
included 12,069
neonatal outcomes subjects with available
associated with
information on
smoking, both
marijuana use and
marijuana and
pregnancy outcomes.
tobacco, and to
Since 2011, they had
evaluate for
routinely questioned all
adverse outcomes gravidae regarding use
alone or in
of marijuana, tobacco,
combination.
and nicotine-containing
Sample/Setting:
products. Perinatal
Sample: 12,069
outcomes in marijuana
women with
smokers vs.
singleton
nonsmokers, as well as
pregnancies who
patients reporting both
delivered at one of marijuana and cigarette
the tertiary
smoking.
referral hospitals
Multivariate analysis
associated with
enabled determination
Baylor College of of adjusted odds ratios
Medicine.
for maternal and fetal
Johns Hopkins
outcomes, adjusting for
Evidence
cofounders.
Appraisal:
Strength: Level
Significance was
III for quantitative determined with MannQuality: Good
Whitney U, X2, and
quality due to a
Fisher exact tests (as
sufficient sample
appropriate).
size, and
reasonably
consistent results.

Results

Strengths/Limitations

Marijuana use alone
was not associated
with a significant
difference in head
circumference <25th
percentile or
birthweight <25th
percentile. However,
cigarette smoking was
found to be
significantly
associated with the
rate of delivery of
relatively small-forgestational age
neonates.
Specifically, in
multivariate-adjusted
models, head
circumference <25th
percentile was
significantly more
common among
smokers.
Pregnancies occurring
among gravidae with
marijuana use were
not found to be
associated with an
increased rate or
occurrence of preterm
birth. However,
preterm birth was
significantly
increased in women
reporting cigarette
smoking as well as
both cigarette

Strengths:
A large, clinically
relevant cohort was
utilized.
The results were
stratified by race and
ethnicity and therefore
could potentially be
generalizable to a
number of populations.
Cigarette use and
marijuana use were
able to be delineated
which could
potentially be used to
provide new insight
into a synergistic
relationship.
Data was not only
curated from electronic
medical records but
also from personal
interviews and direct
patient questioning in
each subject’s native
language.
Limitations:
In a database this large
there are going to be
unaccounted for
cofounders and
occasional missing
data.
Patient reported use of
marijuana use within
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smoking and
marijuana use.
Conclusion:
In the initial cohort
analysis, after
controlling for
potential confounders,
while marijuana
exposure alone was
not associated with
significant perinatal
adverse outcomes, couse with cigarette
smoking rendered
increased risk over
either alone. Due to
observed prevalence
of
concurrent cigarette
and marijuana use, it
is of likely
importance to counsel
patients regarding use
in pregnancy.

the population for this
study was notably
lower than reported
rates of use.

Author Recommendations:
In summary, in our contemporary population-based study we analyzed the impact of maternal
tobacco and marijuana, alone and in combination, on multiple perinatal outcomes. The authors
hope that their study will prompt further analysis inclusive of prospective evaluations, with
consideration for possible synergism of tobacco and cannabis effects on perinatal health. With
these and other studies’ future findings, we will be able to best counsel patients regarding
potential risks as marijuana use becomes more widely accepted.
Summary for current clinical practice question:
This study shows us that marijuana use alone was not associated with significant perinatal
adverse outcomes. Co-use with cigarettes rendered increased risk of significant perinatal
adverse outcomes over either alone. We are seeing more co-use of cigarette and marijuana use
and therefore it is of importance to counsel patients during pregnancy regarding the use of
these substances together.
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Source:
Conner, S. N., Carter, E. B., Tuuli, M. G., Macones, G. A., & Cahill, A. G. (2015). Maternal
marijuana use and neonatal morbidity. American Journal of Obstetrics & Gynecology, 213(3),
422.e1-422.e4. https://doi-https://doi.org/10.1016/j.ajog.2015.05.050
Purpose/Sample Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Retrospective cohort study A total of 674
Strengths:
To determine the of all successive term
patients (8.3%) had This study provides,
occurrence and
deliveries occurring over a the composite
new, valuable
risk factors for
4- year period. Women
outcome. The
information regarding
marijuana use in with marijuana use during composite
neonatal outcomes not
pregnancy and to pregnancy, either by selfof neonatal
previously reported.
morbidity was
evaluate whether report or positive
This study
found in 11.6% of
marijuana use is urine drug screen, were
allowed evaluation of
compared with women
women who used
autonomously
more subtle markers of
who did not use marijuana. marijuana
associated with
neonatal morbidity.
compared with
poor neonatal
Finally, by focusing on
Inclusion criteria consisted 8.0% of women
outcomes.
live births and term
of all women with term,
who did not. After
deliveries, we
live,
adjusting for
can exclude many
singleton pregnancies who smoking tobacco,
potential confounding
other drug use, and factors.
Sample/Setting: delivered at Washington
University in St. Louis
African American
All term
deliveries
Medical Center during the race the composite
occurring over a study period.
neonatal morbidity
4-year period
Exclusion criteria were
was not
from 2004 to
met for women
significantly
2008 at
with preterm deliveries,
different between
Washington
known fetal congenital
women who used
University in St
anomalies, or multiple
marijuana during
Limitations:
Louis Medical
gestations.
pregnancy and
Unable to control for
Center. 8138
those who did not
marijuana smoked.
women met all
For all women in the
Defining marijuana
inclusion
study, detailed
use through self-report
criteria.
demographic information
Conclusion:
may have led to a
was removed from the
This study found
misclassification bias.
medical record by trained
marijuana use is
Study was done in a
obstetric research nurses.
common
tertiary hospital with a
in pregnancy, with
high African American
Data gained included
Level of
patient medical and
8.4% of this studies population.
evidence:
surgical history, obstetric
population found to
Level 1
and gynecological history, use marijuana. This
prenatal history,
study found that
antepartum records,
after adjusting for
delivery records, and
confounding
postpartum records.
factors, term infants

52
Quality of
evidence:

The primary outcome
of women who use
measures were
marijuana during
composite neonatal
pregnancy are not
Good; ample
morbidity and its distinct
at an increased risk
sample size, but components. Measures of
for neonatal
no controls.
neonatal morbidity
morbidity.
included birthweight less
than 2500 g, neonatal
intensive care (NICU)
admission, 5-minute Apgar
score less than 7,
and umbilical artery pH
less than 7.10. Infants with
1 or more morbidities were
considered positive for
neonatal composite
morbidity. Infants with
more than 1 criterion for
neonatal morbidity were
counted only once.
Author Recommendations:
Further study is needed for controlling for the amount and extent of marijuana use and
trimester of use as well as applying objective analyses to determine use to more definitively
determine the relationship between marijuana and adverse neonatal outcomes.
Summary for current clinical practice question:
The practice of marijuana use is increasing making it likely that use in the obstetric population
will increase as well. It is important that practitioners be able to adequately counsel patients
who use marijuana regarding the potential effects on their pregnancy.
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Source: Corsi, D., Walsh, L., Weiss, D., Hsu, H., El-Chaar, D., Hawken, Fell, D., & Walker,
M. (2019). Association between self-reported prenatal cannabis use and maternal, perinatal,
and neonatal Outcomes. JAMA, 322(2), 145–152. doi:10.1001/jama.2019.8734
Purpose/Sample Design
(Method/Instruments)
Purpose:
Population-based
To assess
retrospective cohort study
whether there are covering live births and
associations
stillbirths. The primary
between selfoutcome was preterm birth
reported prenatal before 37 weeks’
cannabis use and gestation. Ten secondary
adverse maternal outcomes were examined
and perinatal
including small for
outcomes.
gestational age, placental
abruption, transfer to
Sample/Setting: neonatal intensive care,
Women aged 15 and 5-minute Apgar score.
years and older
Coarsened exact matching
in Ontario,
techniques and Poisson
Canada, between regression models were
April 2012 and
used to estimate the risk
December 2017. difference (RD) and
This study
relative risk (RR) of
included 661,617 outcomes associated with
pregnancies and cannabis exposure and
9427 reported
control for confounding.
cannabis users

Level of
evidence:
III
Quality of
evidence:
Good

Results

Strengths/Limitations

The rate of preterm
birth among
reported cannabis
users was 12% vs
6% in nonusers, a
statistically
significant
difference.

Strengths:
The matched cohort
was balanced across
covariates, including
maternal age,
socioeconomic status,
tobacco smoking, and
other correlates of
cannabis exposure. A
large, populationbased pregnancy
cohort, a significant
association was
observed between
reported prenatal
cannabis use and
preterm birth.

Conclusion:
Among pregnant
women in Ontario,
Canada, reported
cannabis use was
significantly
associated with an
increased risk of
preterm birth.
Findings may be
limited by residual
confounding.

Limitations:
Findings may be
limited by residual
confounding. In
BORN and other
administrative data,
there is likely
misclassification of
cannabis exposure in
pregnancy. The
sources may be
influenced by social
stigma, desirability
bias, and fear of
intervention by child
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protection or social
services.

Author Recommendations:
Recent evidence suggests that cannabis use during pregnancy is increasing, although
population-based data about perinatal outcomes following in utero exposure remain limited.
Summary for current clinical practice question:
Need for further research to determine if preterm birth is increased with marijuana use.
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Source:
Crume, T. L., Juhl, A. L., Brooks-Russell, A., Hall, K. E., Wymore, E., & Borgelt, L. M.
(2018). Cannabis use during the perinatal period in a state with legalized recreational and
medical marijuana: The association between maternal characteristics, breastfeeding Patterns,
and neonatal outcomes. The Journal of Pediatrics, 197. 90-96.
https://doi.org10.1016/j.jpeds.2018.02.005
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
A cross-sectional study The overall
Strengths:
To evaluate
was conducted using
prevalence of
The PRAMS is the
prevalence
population-based data
cannabis use at any
largest state-based
estimates of
regarding cannabis use time during
surveillance program
prenatal and early during and after
pregnancy was 5.7%
of pregnant women
postnatal
pregnancy from a
(95% CI, 4.8%and live births in
marijuana use in a stratified random
6.8%).
Colorado.
state that has
sample of women who The analytic sample
The neonatal outcomes
legalized
delivered a live-born
variables were chosen
was 3178 for LBW,
medicinal and
infant between January 3146 for NICU
based on previous
recreational
1, 2014 and December admission, 3178 for
literature suggesting
marijuana and the 31, 2015.
high validity.
preterm birth, and
association with
2983 for small for
adverse neonatal
Neonatal outcomes of
gestational age.
outcomes.
interest abstracted from Cannabis use at any
the Colorado birth
time during
Sample/Setting:
certificate included:
pregnancy was
3207 respondents
Limitations:
LBW (birth weight of
associated with 80%
from the 2014Maternal cannabis use
<2500g), preterm birth increased likelihood
2015 Colorado
was self-reported
(birth at <37 weeks),
of LBW (OR, 1.8;
Pregnancy Risk
small for gestational
95% CI, 1.3-2.4; P = which could result in
Assessment
misinformation being
age (birth weight of
.0008), independent
Monitoring
given.
less than or equal to
of maternal age,
System with state- 10% for gestational age race/ethnicity, and
developed
based standardized
level of maternal
questions on
national sex-specific
education.
cannabis use.
Conclusion:
infant growth charts),
Johns Hopkins
The findings from
and NICU admission.
Evidence
this study highlight
The relationship
Appraisal:
the importance of
between maternal
Strength:
screening for
cannabis use at any
Level III due to it time during pregnancy cannabis use during
pregnancy and the
being a crossand adverse neonatal
sectional study,
outcomes (LBW, small need for counseling
about the adverse
which is an
for gestational age,
health consequences
observational type NICU admission, and
of continued use
preterm birth) was
of study and is
nonexperimental.
evaluated in separate
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Quality:
High quality due
to the consistent,
generalizable
results, and
sufficient sample
size. This study
also provides
consistent
recommendations.

multiple logistic
regression models.

during pregnancy and
lactation.
It was found that
maternal cannabis use
at any time during
pregnancy was
associated with a
50% increased
likelihood of LBW,
independent of
tobacco use during
pregnancy and other
confounders.

Author Recommendations:
Our findings of a relationship between prenatal cannabis use and LBW underscore the 2015
recommendations by the American College of Obstetricians and Gynecologists for clinical
management of cannabis use during pregnancy and lactation. Pregnant women should be
asked about cannabis use and advised to discontinue cannabis use during pregnancy and
lactation. Obstetrics providers should refrain from prescribing or recommending cannabis for
medical purposes during preconception, pregnancy, and lactation. Given the higher levels of
use among women of younger age and lower socioeconomic status, guidance and messaging
should be incorporated into prenatal care, WIC, and Medicaid services. Screening of pregnant
women at risk for cannabis dependency should be linked to treatment options and, based on
this study, should include the assessment of other maternal risk factors such as tobacco use,
stress, food insecurity, and prenatal vitamin use.
Summary for current clinical practice question:
Marijuana use should be advised against during any point in the pregnancy due to the strong
correlation to lower birth weight infants being born to mothers who used marijuana in their
pregnancies. Small for gestational age, preterm birth, and neonatal intensive care unit
admission were not associated with prenatal cannabis use, independent of prenatal tobacco
use.
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Source: Day, N. L., Goldschmidt, L., & Thomas, C. A. (2006). Prenatal marijuana exposure
contributes to the prediction of marijuana use at age 14. Addiction, 101, 1313-1322.
https://doi.org/10.1111/j.1360-0443.2006.01523.x
Purpose/Sample Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Study began in 1982
Prenatal marijuana
Strengths:
To determine the
when the mothers were exposure predicted
The results agree with
effects of prenatal in their fourth prenatal age of onset and
other reports that have
marijuana
month.
frequency of
found a preponderance
exposure on the
2 study cohorts were
marijuana use
of child factors as
formed.
age of onset and
amongst 14-year-old
predictors of early
frequency use
- women who
offspring even when
onset substance use.
used marijuana all variables in the
amongst 14-yearolds.
at least twice
data were considered. There was an adequate
per month
number of women who
- women who
Current maternal
participated in the
used less than
tobacco use was
study who used
twice a month
significantly
marijuana prenatally
associated with the
or none at all.
Women were also
frequency of
Sample/Setting:
Women were followed
th
adolescent marijuana throughout pregnancy
Sample was from interviewed in their 7
recruitment out of prenatal month, at
use.
and multiple times
a hospital-based
throughout childhood.
delivery, at 8 and 18
prenatal clinic.
months postpartum,
Maternal depression
Women aged 18was significantly
Limitations:
and 3,6,10 & 14 years
42.
The cohort was
associated with an
postpartum.
Half were African
weighted toward
earlier age of
American, and
substance-using
Two outcome variables initiation in the
half were
women making it less
were used for the
offspring.
Caucasian.
generalizable.
analyses.
Most from lower
Child’s gender, race,
- age of
socioeconomic
marijuana onset and IQ did not predict The women in the
status.
study were mostly
age of onset or
- frequency of
Most were light to
from lower
frequency
of
marijuana use
moderate
socioeconomic status,
marijuana use at age
substance users
which makes the study
14.
during pregnancy
less generalizable to
and subsequently.
the general public.
563 pairs (mother
Conclusion:
and daughter)
Prenatal exposure to
were included in
marijuana, in addition
this study.
to other factors, is a
Johns Hopkins
significant predictor
Evidence
of marijuana use at
Appraisal:
age 14.
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Strength:
Level III
Quality:
Good

Author Recommendations:
There are 3 mechanisms by which prenatal marijuana exposure could predict marijuana use in
offspring. This could result from:
1. Genetic or familial factors
2. Characteristics of the current environment
3. Gestational exposures
More studies in these areas will go on to provide more information.
Summary for current clinical practice question:
Even though we don’t have strong evidence showing an association between prenatal
marijuana exposure and birth defects, the data from this study can show parents that marijuana
exposure prenatally can possibly predict the use in their offspring, and this is an important
thing to counsel our patients on.
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Source: De Genna, N., Cornelius, M., Goldschmidt, L., & Day, N. (2015). Maternal age and
trajectories of cannabis use. Drug and Alcohol Dependence, 156, 199-206.
https://doi.org/10.1016/j.drugalcdep.2015.09.014
Purpose/Sampl
e

Design
(Method/Instruments
)
Purpose:
This prospective study
The goal of this examined 456
study was to
pregnant women
identify
recruited at a prenatal
trajectories of
clinic, ranging in age
maternal
from 13 to 42 years.
cannabis use,
The women were
and to determine interviewed about their
if maternal age
cannabis use 1 year
was associated
prior to pregnancy and
with different
during each trimester
trajectories of
of pregnancy, and at 6,
use.
10, 14, and 16 years
post-partum.
Sample/Setting:
Data for this
study are from
three birth
cohorts that are
part of a
consortium of
studies on the
effects of
substance use on
offspring
physical and
neurobehavioral
development.
These data were
collected as part
of three NIHfunded studies:
the teen mother
cohort and two
adult mother
cohorts. The two
adult mother
cohorts were
combined. Teen

Results

Strengths/Limitation
s

A growth mixture model
of cannabis use reported
at each time point
clearly delineated four
groups: non/unlikely to
use, decreasing
likelihood of use, late
desistance, and
increasing
likelihood/chronic use
(Lo–Mendell–Rubin
adjusted LRT test
statistic = 35.7, p < .001)
. The youngest mothers
were least likely to be in
the “non/unlikely to use”
group. Younger
maternal age also
differentiated between
late desistance and
increasing
likelihood/chronic use,
versus decreasing
likelihood of use postpartum.

Strengths:
This study provided
the first empirical
evidence that age does
matter for trajectories
of maternal cannabis
use.

Conclusion:
This is the first study to
demonstrate that
younger mothers are
more likely to use
cannabis across 17

Limitations:
These results may not
generalize to mothers
from other regions of
the country, to
mothers of other racial
and ethnic
backgrounds, or to
mothers from more
advantaged
backgrounds who do
not give birth in an
urban, university
teaching hospital. This
study provides no data
on cannabis use in
mothers of Hispanic
or Asian-American
descent. Another
limitation of the
current study is the
reliance on self-report
for cannabis use.
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Cohort mothers
were 13–18
years old and
Adult Cohort
mothers were
18–42 years old
at the beginning
of the studies

years, including later
desistance post-partum
and increasing/chronic
use.
Other substance use and
chronic depressive
symptoms were also
associated with more
frequent use.

Level of
evidence:
III
Quality of
evidence:
Good
Author Recommendations:
These findings have implications for both prevention and treatment of cannabis use in
mothers.
Summary for current clinical practice question:
These results have important implications for the physical and mental health of our youngest
mothers, given the effects of cannabis use on the still-developing adolescent brain.
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Source:
El Marroun, H., Tiemeier, H., Steegers, E., Jaddoe, V., Hofman, A., Verhulst, F., Brink, W.,
Huizink, A. (2009). Intrauterine cannabis exposure affects fetal growth trajectories: the
generation r study. Journal of the American Academy of Child & Adolescent
Psychiatry, 48(12), 1173-1181. https://doi.org/10.1016/s1090-798x(10)79394-2
Purpose/Sample Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Approximately 7,452
Maternal cannabis
Strengths:
This study
mothers enrolled during
use during
Strengths of this
examined the
pregnancy and provided
pregnancy was
investigation include
relation between
information on substance
associated with
the large populationmaternal cannabis use and fetal growth. Fetal growth restriction
based prospective
use and fetal
growth was determined
in mid- and late
cohort we used to
growth until birth using ultrasound measures pregnancy and with examine these
in a populationin early, mid-, and late
lower birth weight. associations, the use of
based sample.
pregnancy. Additionally,
This growth
ultrasound
birth weight was assessed. reduction was most measurements in
Sample/Setting:
pronounced for
combination with
fetuses exposed to
information collected
continued maternal at birth that enabled us
cannabis use during to determine growth
pregnancy. Fetal
trajectories throughout
Level of
weight in cannabis- gestation until birth,
evidence:
exposed fetuses
and the possibility to
showed a growth
control for important
III
reduction of j14.44 confounding factors,
g/week (95%
including lifestyle
Quality of
confidence interval factors, socioeconomic
evidence:
j22.94 to j5.94, p = factors, and known
.001) and head
determinants of fetal
Good
circumference
growth.
(j0.21 mm/week,
95% confidence
interval j0.42 to
0.02, p = .07),
compared with
nonexposed fetuses.
Maternal cannabis
Limitations:
uses during
Used self-reported data
pregnancy resulted on substance use. Both
in more pronounced potential
growth restriction
misclassification and
than maternal
selection bias may
tobacco use.
have led to an
Paternal cannabis
underestimation of the
use was not
prevalence of cannabis
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associated with
fetal growth
restriction.

Conclusion:
Maternal cannabis
use, even for a
short period, may
be associated with
several adverse
fetal growth
trajectories.

use and an
underestimation of the
effects of cannabis
exposure on fetal
growth and brain size
parameters. The
effects of maternal
cannabis use on fetal
characteristics may
have been
underestimated
because the early
pregnancy
measurements were
used for pregnancy
dating, if the variation
in growth before the
first measurement is
zero.

Author Recommendations:
Our findings suggest the importance of educating future mothers about the consequences of
prenatal maternal cannabis use. Our findings may imply that different messages could be
transmitted to tobacco and cannabis users.
Summary for current clinical practice question:
To prevent the potential harmful effects of intrauterine cannabis exposure, women should quit
using cannabis before conception.
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Source: Ko, J., Farr, S., Tong, V., Creanga, A., & Callaghan, W. (2015). Prevalence and
patterns of marijuana use among pregnant and nonpregnant women of reproductive age.
American Journal of Obstetrics & Gynecology, 213(2), 201-211.
https://doi.org/10.1016/j.ajog.2015.03.021
Purpose/Sample Design
(Method/Instruments)
Purpose:
The study combined
The objective of public use data from the
the study was to 2007/2012 National
provide national Surveys on Drug Use and
prevalence,
Health (NSDUH). The
patterns, and
NSDUH is a crosscorrelates of
sectional survey designed
marijuana use in to estimate prevalence and
the past month
correlates of substance use
and past 2/12
in US household
months among
populations aged 12 years
women of
or older.
reproductive age
by pregnancy
status.
Sample/Setting:
Pregnant and
nonpregnant
women 18-44
years of age.
Women selfreported
marijuana use in
the past month
and past 2-12
months (use in
the past year but
not in the past
month).
Level of
evidence:
III
Quality of
evidence:

Results

Strengths/Limitations

More than 1 in 10
pregnant and
nonpregnant women
reported using
marijuana in the
past 12 months. A
considerable
percentage of
women who used
marijuana in the
past year were daily
users, met abuse
and/or dependence
criteria, and were
polysubstance users.

Strengths:
Findings from this
study have clinical and
public health
implications.

Conclusion:
Comprehensive
screening, treatment
for use of multiple
substances, and
additional research
and patient
education on the
possible harms of
marijuana use are
needed for all
women of
reproductive age

Limitations:
Pregnancy status was
self-reported at the
time of the interview;
nonpregnant women
who did not yet know
that they were
pregnant may have
been misclassified.
Furthermore,
marijuana use in the
past 2-12 months may
not have occurred
during pregnancy.
Second, marijuana and
other substance use
were self-reported and
not validated with
biological samples.
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Strong
Author Recommendations:
Clinicians should be aware of the prevalence of marijuana use among their patients who are
pregnant or at risk of becoming pregnant and have the training, tools, and resources to provide
appropriate screening, patient education and care to women using or abusing marijuana,
including comprehensive treatment for women also using other substances.
Summary for current clinical practice question:
As states legalize the medical and/or recreational use of marijuana, it will be important to
continuously monitor national and state trends in their use and examine potential adverse
effects on pregnancy.
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Source: Leemaqz, S. Y., Dekker, G. A., McCowan, L. M., Kenny, L. C., Myers, J. E.,
Simpson, N., Poston, L., & Roberts, C. T. (2016). Maternal marijuana use has independent
effects on risk for spontaneous preterm birth but not other common late pregnancy
complications. Reproductive Toxicology, 62, 77-86.
https://doi.org/10.1016/j.reprotox.2016.04.021
Purpose/Sample
Purpose:
This study aimed
to examine the
association of
maternal
marijuana use
(from prepregnancy and up
to 20 weeks’
gestation) in a
multi-center
cohort with major
pregnancy
complications,
amongst both
cigarette smokers
and non-smokers,
controlling for
well-known risk
factors, as well as
its effects on
length of
gestation.
Sample/Setting:
A total of 5588
participants were
included in the
analysis, with
1155 participants
recruited from
Australia, 2014
from New
Zealand, 1765
from Ireland, and
654 from the
United Kingdom.

Design
(Method/Instruments)
Details of maternal
age, BMI and
socioeconomic index
(SEI), medical and
family history, along
with dietary and
lifestyle questionnaires
with self-reported
marijuana and cigarette
smoking were recorded
at 15 weeks’ and 20
weeks’ gestation and
entered into an
internet-accessed
database.
Breslow-Day test was
used to assess the
homogeneity of the
odds of marijuana use
between cigarette
smokers and nonsmokers, along with an
adjusted common odd
estimated from MantelHaenszel test.
Marijuana and cigarette
smoking status were
then analyzed with
mixed effects logistic
regression to determine
the association with
pregnancy outcomes,
adjusting for maternal
age, BMI and SEI, and
with recruiting center
differences accounted
for as a random effect.
A linear mixed model

Results

Strengths/Limitations

Marijuana use and
cigarette smoking at
20 weeks of gestation
were both associated
with small gestation
age (SGA) and
spontaneous preterm
birth (SPTB).
The odds of SPTB for
any marijuana use
three months prior to
or during pregnancy
was more than
doubled for both
cigarette smokers and
non-smokers.
Similarly, as
expected, continuing
to smoke cigarettes at
20 weeks’ gestation
was associated with
SGA.
The predicted length
of gestation was
lower for women who
continued to use
marijuana at 20
weeks of gestation for
both cigarette
smokers and nonsmokers, with an
estimated gestation of
less than 37 weeks
when more than 100
episodes of marijuana
use within the
previous three months

Strengths:
A strength of this
study was its large
international
multicenter
prospective cohort
with excellent followup and complete data
available for this
analysis. Interaction
tests were performed
on this data. Hence,
with complete quality
data available from
this study, interactions
between marijuana use
and cigarette smoking
status may be
examined while also
adjusting for potential
confounders.
Limitations:
The use of selfreported marijuana
use, and cigarette
smoking status is a
limitation as this can
be subject to
participant recall bias.
This study was also
only carried out on
nulliparous women,
which means the
findings may only
apply to nulliparous
women.
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Johns Hopkins
Evidence
Appraisal:
Strength:
Level III due to it
being a
nonexperimental
study.
Quality:
Good quality due
to sufficient
sample size and
reasonably
consistent
recommendations.

was also fitted for
length of gestation,
with quadratic terms
for the number of times
marijuana was used
over the preceding 3
months at 15 and 20
weeks of gestation,
age, and BMI, to
investigate the dose
effect of marijuana and
cigarette smoking
status on the length of
gestation adjusted for
other factors in the
model.

before 20 weeks’
gestation.
Conclusion:
Based on the current
findings and some
earlier reports, it is
likely that maternal
marijuana use is an
independent risk
factor for SPTB.
If there was no
maternal marijuana
exposure the
incidence of SPTB
would be expected to
decrease by 3 cases
per 1000 pregnant
women.

Author Recommendations:
The data indicates that increasing use of marijuana among young women of reproductive age
is a major public health concern. The increasing exposure to marijuana in women of
reproductive age and its contribution to the risk for preterm birth make it a modifiable target
for intervention.
Summary for current clinical practice question:
In this large prospective cohort, maternal marijuana use had a major contribution to SPTB and
this association was consistent for both cigarette smokers and non-smokers, with doubled odds
in women who used marijuana three months prior to or during pregnancy. For women who use
marijuana during pregnancy, it should be emphasized that stopping early in pregnancy should
be encouraged since continued use of marijuana at 20 weeks of gestation was associated with a
five-fold increased risk of SPTB in this study following adjustment for other confounders,
including maternal age, BMI, SEI, and cigarette smoking. In this cohort of nulliparous women,
we estimate there would be an estimated 6.2% reduction in the incidence of SPTB if women
were not exposed to marijuana during pregnancy.
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Source: Mark, K., Desai, A.N., & Terplan, M. (2015). Marijuana use and pregnancy:
prevalence, associated characteristics, and birth outcomes. Archives of Women's Mental
Health, 19, 105-111. https://doi.org/10.1`007/s00737-015-0529-9
Purpose/Sample Design
(Method/Instruments)
Purpose:
A chart review of all
This study
patients presenting for
examines the
prenatal care at a single,
prevalence,
urban, university-affiliated
behaviors, and
clinic from July 1, 2009 to
birth outcomes
June 30, 2010 was
associated with
performed. Intake data
marijuana use in were retrieved from the
pregnancy.
prenatal chart which
included a complete social
work evaluation. Prenatal
Sample/Setting: care visits, labor and
This was a
delivery triage visits, and
retrospective
postpartum visits were
cohort from a
obtained from billing
university-based records. Birth outcome
prenatal care
data were retrieved from
clinic from July hospital records, delivery
1, 2009 to June
summaries, and
30, 2010. The
postpartum follow-up.
primary
exposure was
marijuana use,
defined by selfreport or urine
toxicology.
Level of
evidence:
III
Quality of
evidence:
good

Results

Strengths/Limitations

Marijuana use was
not related to
incidence of low
birth weight (13.8
% vs 14.0 %, p=
1.00), preterm
delivery (17.7 % vs
12.0 %, p=0.325),
or NICU admissions
(25.5 % vs 15.8 %,
p=0.139). Prenatal
care utilization was
equal between
marijuana users and
non-users.

Strengths:
There were several
differences in
demographics,
behaviors, and
psychosocial
characteristics in the
cohort who used
marijuana as compared
with those who did
not. Most significant
was the correlation
between tobacco use
and marijuana use.

Conclusion:
Data demonstrates
that marijuana use
in early pregnancy
is common, as is
cessation of use by
delivery. Marijuana
use is associated
with use of other
substances, most
notably tobacco.
The impact of
marijuana on birth
outcomes was
limited.

Limitations:
This is a retrospective
cohort that relies
partially on provider
documentation of
screening. There may
have also been
selection bias as not all
patients were
consistently screened
with urine toxicology.
Additionally, the
frequency of marijuana
use was not elicited,
nor was detailed
information about a
quit date obtained.
These facts limit our
ability to determine
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any type of dosedependent relationship
with birth outcomes.
Author Recommendations:
As the rates of marijuana use in pregnancy are increasing, larger prospective trials on the
impact of varying levels of marijuana use on birth outcomes and long-term development are
warranted.
Summary for current clinical practice question:
More large studies need to be investigated.
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Source: Martin, C., Longinaker, N., Mark, K., Chisolm, M., Terplan, M. (2015). Recent
trends in treatment admissions for marijuana use during pregnancy. Journal of Addiction
Medicine, 9(2), 99-104. https://doi.org/10.1097/adm.0000000000000095
Purpose/Sam
ple
Purpose:
The objective
of this study
was to
investigate
recent trends
in marijuana
use during
pregnancy in
the United
States.
Sample/Settin
g:
The data set is
estimated to
include 83 %
of all eligible
drug or
alcohol
treatment
admissions in
the United
States

Level of
evidence:
III
Quality of
evidence:
Good

Design
(Method/Instrume
nts)
Data was obtained
from the Treatment
Episodes Data Set
from 1992-2012
and analyzed for
trends over time
using X, CochranArmitage, and
Moran’s I tests.

Results

Strengths/Limitati
ons

The proportion
of treatment admissions for
women who were pregnant
remained stable at 4%;
however, admissions of pregnant
women reporting
any marijuana use increased
substantially from 29% to 43%
(P < 0.01). The West North
Central census division (20%)
experienced the greatest increase
followed by the Middle Atlantic
(18%) and Pacific (14%)
divisions. The demographic
characteristics of
regnant marijuana admissions ch
anged over time, with white nonHispanic women, criminal
justice referrals, and those with a
psychiatric comorbidity
becoming more common
whereas polysubstance users
decreased (P < 0.01).

Strengths:
The matched
cohort was
balanced across
covariates,
including maternal
age, socioeconomic
status, tobacco
smoking, and other
correlates of
cannabis exposure.
A large,
population-based
pregnancy cohort, a
significant
association was
observed between
reported prenatal
cannabis use and
preterm birth.

Conclusion:
Even though more women
using marijuana are seeking and
receiving substance
abuse treatment during pregnanc
y, targeting certain risk groups
while improving screening
and treatment referral systems
by health care providers, such as
prenatal caregivers, should be
emphasized.

Limitations:
Findings may be
limited by residual
confounding. In
BORN and other
administrative data,
there is likely
misclassification of
cannabis exposure
in pregnancy. The
sources may be
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influenced by
social stigma,
desirability bias,
and fear of
intervention by
CPS

Author Recommendations:
Prenatal care and substance use programs need to better tailor their interventions to the
changing demographics to better meet the needs of substance using mothers.

Summary for current clinical practice question:
Interventions should focus on screening and treatment referral by health care providers as we
are in the preferred position to provide the access and address barriers to care.
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Source:
Metz, T., Allshouse, A., Hogue, C., Goldenberg, R., Dudley, D., Varner, M., Conway, D.,
Saade, G., Silver, R. (2017). Maternal marijuana use, adverse pregnancy outcomes, and
neonatal morbidity. American Journal of Obstetrics & Gynecology, 217(4), 478.e1-478.e8.
https://doi.org/10.1016/j.ajog.2017.05.050
Purpose/Sample Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
Case controlled study.
Maternal marijuana Strengths:
To examine if
In the SB group, there
use was not
The use of biological
maternal
were 707 fetuses. Of these associated with a
sampling from
marijuana use is cases, 654 (98.6%) had
composite adverse
umbilical cord
associated with
placental examination. Of pregnancy outcome homogenate to
increased odds
these LB controls, 1804
of SGA, SPTB, and objectively assess
of adverse
(93.4%) had placental
HTN independent
maternal marijuana
pregnancy
examination. The SCRN
of tobacco use, but
use. There was
outcomes and
study encompassed a Data was associated with vigorous data
neonatal
Coordinating and Analysis neonatal morbidity. collection by trained
morbidity among Center (DCAC), Research
people, populationlive-born
Triangle Park (RTI)
based sampling
controls.
International, North
resulting in a racially,
Carolina, and five clinical
ethnically, and
Sample/Setting: sites: Brown University,
geographically diverse
663 still births
Rhode Island; Emory
Conclusion:
population; large
University, Georgia;
and 1932 live
Maternal marijuana sample size.
University of Texas
births. The
use was 2.7 %,
Medical Branch at
SCRN study
tobacco use was
Galveston, Texas;
encompassed a
12.9%. Adverse
University of Texas
Data
pregnancy
Health Sciences Center at outcomes were
Coordinating
San Sciences Center,
and Analysis
greater in this
Limitations:
Center (DCAC), Utah.
group, though not
Maternal marijuana uses
Infrequency of
Research
significantly
as measured by self-report reportable.
Triangle Park
marijuana use in this
and/or the presence of 11cohort, and the lack of
(RTI),
nor-delta-9International,
available data
tetrahydrocannabinol-9North Carolina,
regarding individual
use patterns. There
and five clinical carboxylic acid (THCCOOH) in umbilical cord
sites: Brown
was poor agreement
homogenate. abstraction
University,
between self-reported
by the research team.
Rhode Island;
marijuana use and
Emory
objective
University,
documentation,
Georgia;
limiting the value of
University of
self-reported data.
Texas Medical
There is no long-term
Branch at
follow-up data on
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Galveston,
Texas;
University of
Texas Health
Sciences Center,
Utah.

the neonates to assess
for childhood
outcomes.

Level of
evidence:
III
Quality of
evidence:
High;
Multivariable
logistic
regression
models. Large
sample study and
dependable
results.
Author Recommendations:
Further studies are needed to determine whether the use of marijuana in pregnancy causes
adverse perinatal outcomes.
Summary for current clinical practice question:
Providers need to be able to educate women about the anticipated effects of maternal
marijuana use in pregnancy.
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Source:
Oh, S., Salas-Wright, C., Vaughn, M., & DiNitto, D. (2017). Marijuana use during pregnancy:
a comparison of trends and correlates among married and unmarried pregnant women. Drug
and Alcohol Dependence, 181, 229-233. https://doi.org/10.1016/j.drugalcdep.2017.09.036
Purpose/Sample Design
(Method/Instruments)
Purpose:
Data resulting from the
To examine
National survey on Drug
trends and links
Use and Health from
of prenatal
2005-2014. The
marijuana use
significance of marijuana
and the effects of use was tested using
marijuanalogistic regression analysis
specific
while adjusting for
risk/protective
complex sampling design
influences on
effects and controlling for
marijuana use
sociodemographic and
trends.
marijuana-specific factors.

Sample/Setting:
Data was from
the National
Survey on drug
use. Include
were 3640
married women
and 3987
unmarried
pregnant women
in the United
States.

Level of
evidence:
III
Quality of
evidence:

7627 female respondents
aged 18-44 were included
in the final analytical
sample.

Results

Strengths/Limitations

During the data time
2005-2014,
unmarried pregnant
women’s incidence
of marijuana
increased by 85%,
whereas married
pregnant women’s
marijuana use
remained steady.

Strengths:
Large sample size
from a wellestablished national
survey. Consistent
results with other
known studies.

Limitations:
Unable to draw casual
conclusions regarding
the links between
Conclusion:
marijuana use and
Increase the
protective factors or
understanding of
mental health links.
Second, data was selfmarijuana use in
reported therefore it
pregnant women.
Preventative efforts could be over or under
reported. Small
should be made
number of married
with unmarried
women who reported
pregnant women
marijuana use may
with education of
limit the ability to find
potential harmful
effects of marijuana significant
smoking to maternal relationships.
and child health.
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High Quality
Author Recommendations:
Increased attention should be paid to reducing prenatal marijuana use among unmarried
women. Findings also suggest the need to attend to unmarried pregnant women’s mental
health problems as well as their physical health-risk behaviors.
Summary for current clinical practice question:
Education of all pregnant women, but especially unmarried pregnant women on the potential
of adverse effects of marijuana use on maternal and child health.
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Source: Roberson, E., Patrick, W., & Hurwitz, E. (2014). Marijuana use and maternal
experiences of severe nausea during pregnancy in Hawai'i. Hawai'i Journal of Medicine &
Public Health: A Journal of Asia Pacific Medicine & Public Health, 73(9), 283-7.
Purpose/Sample Design
(Method/Instruments)
Purpose:
Secondary analysis.
To determine the Hawaii Pregnancy Risk
prevalence of
Assessment Monitoring
marijuana use,
System (PRAMS) data
during and
from 2009 to 2011 was
immediately
conducted. Follow a
before
standardized data
pregnancy in
collection protocol
Hawaii and
centering on selfdescribe
administered mailed
differences in
questionnaires with
marijuana use
telephone follow-up for
during and
non-responders.
immediately
before
pregnancy in
Hawaii.
Women are selected for
participation in the Hawaii
PRAMS survey as part of
a stratified sample drawn
Sample/Setting: from the certificates of
Data from 4,735 live births in Hawaii
respondents
Participants complete the
were used to
survey 3-8 months
estimate
postpartum, with the
prevalence of
majority responding 3-4
self-reported
months postpartum.
marijuana use
Maternal age,
during and in the race/ethnicity, nativity,
month before
education, and parity were
pregnancy, as
determined based on
well as severe
linked birth certificate
nausea during
variables included in the
pregnancy
Hawaii PRAMS dataset.
Federal Poverty Level
(FPL) was based on
maternal report of
household annual income
and number of dependents

Results

Strengths/Limitations

6.0% (95% CI: 5.26.8) of women
reported using
marijuana in the
month before their
most recent
pregnancy, and
2.6% (95% CI: 2.23.2) reported using
marijuana during
their most recent
pregnancy.
Approximately
21.2% (95%
CI:19.8-22.8) of
women with live
births in Hawaii
reported severe
nausea during their
most recent
pregnancy.
Compared to those
who did not report
severe nausea
during pregnancy,
women who
reported severe
nausea during
pregnancy were
more likely to report
marijuana use
during pregnancy
(3.7% vs 2.3%;
PR=1.63, 95%
CI:1.08-2.44)
(Table 1). This
association was
statistically
significant (P=.034).

Strengths:
This data source has
advantages over
smaller studies in that
it provides populationbased estimates
representing all
pregnancies resulting
in live births in Hawaii
in a given time period.

Limitations:
The data source for
this study relates to the
uniqueness of Hawaii
itself, therefore the
generalizability of
research findings from
studies conducted
outside the state is
unclear.
Questions related to
marijuana use did not
have information on
amount or frequency
of use, pregnancy
trimester of usage, or
if the marijuana was
recreational or
prescribed by a
physician. The survey
question related to
severe morning
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Level of
evidence:

in the year before delivery
and was calculated
according to Hawaii
Level VI
specific threshold
guidelines.
Prevalence estimates,
confidence intervals, and
Quality of
P-values were generated
evidence:
using SAS 9.2 (SAS
High. Large
Institute Inc., Cary, NC)
population size,
and SAS-callable
population-based SUDAAN 10.0 (RTI
estimates. Only
International, Research
studied
Triangle Park, NC) to
Hawaiian
account for complex
pregnancies.
sampling. Chi-square tests
were calculated to
determine statistical
significance. Maternal
age, race/ethnicity,
nativity, education, and
parity.

Conclusion:
The findings could
indicate use of
marijuana as an
anti-emetic among
those experiencing
severe morning
sickness. Marijuana
use before
pregnancy was also
associated with an
increased likelihood
of severe nausea
during pregnancy,
although the
difference was not
statistically
significant.

sickness during. There
may also be some
effects due to mode
bias (mail versus
telephone).

Author Recommendations:
These preliminary findings warrant further research into the subject, with special attention
paid to the relatively rare, but increasingly documented cannabinoid hyperemesis syndrome
(CHS).
Summary for current clinical practice question:
More research is needed to investigate the exact nature of the relationship between marijuana
use and severe nausea during pregnancy.
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Source:
Van Gelder, M., Reefhuis, J., Caton, A., Werler, M., Druschel, C., Roeleveld, N., & The
National Birth Defects Prevention Study. (2009). Maternal Periconceptional Illicit Drug Use
and the Risk of Congential Malformations. Epidemiology, 20(1), 60-66. Retrieved from
www.jstor.org/stable/25662671
Purpose/Sample Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
This study used
In the
Strengths:
To determine if
multivariable logistic
periconceptional
Many of the defects
there are true
regression to estimate the period, 5% of the
included have not been
associations
associations between
15,208 mothers
studied before in
between illicit
cannabis, cocaine, and
reported any use of
relation to
drug use and
stimulant use in the month illicit drugs. We did periconceptional illicit
congenital
before pregnancy or
not find associations substance use. Also,
malformations.
during the first trimester
between illicit drug we implemented an
(periconceptional period)
use and most of the extensive standardized
and the occurrence of
20 eligible
interview that included
Sample/Setting: selected birth defects.
categories of
detailed questions on
Data was
congenital
illicit drug use and
analyzed from
malformations.
important covariates.
the National
Periconceptional
Birth Defects
cannabis use
Prevention
seemed to be
Study, a caseassociated with an
control study of
increased risk of
major birth
anencephaly
defects, and
(adjusted odds ratio
assessed all birth
1.7; 95% confidence Limitations:
defects
interval 0.9 –3.4),
categories in
whereas cocaine use It is likely that the use
which there were
in the
of illicit drugs was
at least 250
periconceptional
underestimated in our
interviewed case
period was
study and other studies
mothers.
associated with the
based on self-report.
risk of cleft palate
Respondents often
(2.5; 1.1–5.4).
falsely deny use
Level of
because of the social
evidence:
stigma associated with
Conclusion:
use and fear of
III
There were very few judgment or
suggestions of
prosecution.
Quality of
positive associations Unintentional denial in
evidence:
between
the form of incomplete
Good
periconceptional
recall might also have
illicit drug use and
been an issue in this
study.

78
the 20 birth defects
categories.

Author Recommendations:
Cannabis use may be associated with an increased risk of anencephaly in offspring, and the
risk of cleft palate appears to be increased for infants exposed to cocaine in the
periconceptional period.
Summary for current clinical practice question:
The present findings showed very few positive associations between periconceptional illicit
drug use and selected birth defects. Although the number of infants exposed to cocaine and
stimulants was low, the statistical power of the data was enough to rule out 2- to 4-fold or
greater increases in the risk of the selected birth defects.
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Source:
Varner, M., Silver, R., Rowland Hogue, C., Willinger, M., Parker, C., Thorsten, V.,
Goldenberg, R., Saade, G., Dudley, D., Coustan, D., Stoll, B., Bukowski, R., Koch, M.,
Conway, D., Pinar, H., & Reddy, W. for the Eunice Kennedy Shriver National Institute of
Child Health and Human Development Stillbirth Collaborative Research Network (2014).
Association between stillbirth and illicit drug use and smoking during pregnancy. Obstetrics
and Gynecology, 123(1), 113–125. doi:10.1097/AOG.0000000000000052
Purpose/Sample Design
(Method/Instruments)
Purpose:
The Stillbirth
To compare
Collaborative Research
illicit drug and
Network conducted a
smoking use in
case–control study.
pregnancies with Umbilical cord samples
and without
from cases and controls
stillbirth.
were collected and frozen
for subsequent batch
analysis. Maternal serum
was collected at delivery
Sample/Setting: and batch analyzed for
March 2006 to
cotinine.
September 2008,
covering more
For 663 stillbirth
than 90% of
deliveries, 418 had cord
deliveries to
homogenate and 579 had
residents of five maternal cotinine assays
priori–defined
performed. For 1,932 live
geographically
birth deliveries, 1,050 had
diverse regions.
cord homogenate
663 stillbirths
toxicology and 1,545 had
and 1,932 live
maternal cotinine assays
births were
performed.
included in the
study

Level of
evidence:
III

Results

Strengths/Limitations

In this populationbased study of
stillbirth, there was a
twofold increase in
stillbirth in women
with positive
umbilical cord
homogenate
screening. The most
common drug
detected was
tetrahydrocannabinol
acid, which was
significantly
associated with
stillbirth (OR 2.34,
95% CI 1.13–4.81).

Strengths:
The study was
population-based and
racially and ethnically
diverse. Participants
were evaluated with a
thorough standardized
protocol that
minimized variability
in data and sample
collection. The study
also included a
maternal interview and
medical record
abstraction to allow for
in-depth questions
about smoking and
drug use. Finally, in
addition to selfreported substance
abuse, exposure to
tobacco and illicit
drugs was confirmed
by analyses that were
blinded to the clinical
outcome.

Conclusion:
Positive toxicology
screen for illicit
drugs was associated
with a two- to
threefold increase in
stillbirth risk.
Documentation of
tetrahydrocannabinol
acid indicating
cannabis use

Limitations:
Participants who did
not have cotinine and
toxicology testing
differed in race or
ethnicity and
gestational age from
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Quality of
evidence:
High

increased the odds of
stillbirth twofold.

those whom samples
were available for
testing, which may
bias our findings.
Second, drug use
during pregnancy
declines at term, which
may have been another
source of bias. The
study also lacked a
sample size to make
definitive conclusions
regarding the
relationship between
some individual drugs
and stillbirth and
among cannabis use,
smoking, and stillbirth.

Author Recommendations:
Cannabis users often smoke as well, and more research is needed to investigate the interaction
of tetrahydrocannabinol acid and cigarette smoking.
Summary for current clinical practice question:
Cannabis use may be increasing with increased legalization; clinicians should be alert to these
risks and should educate women regarding dangers associated with marijuana use and active
and passive smoke exposure during pregnancy.
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Source: Warshak, CR., Regan, J., Moore, B., Magner, K., Kritzer, S., & Van Hook, J. (2015).
Association between marijuana use and adverse obstetrical and neonatal outcomes. Journal of
Perinatology, 35, 991-995. https://doi.org/10.1038/jp.2015.120
Purpose/Sample
Design
Results
Strengths/Limitations
(Method/Instruments)
Purpose:
A retrospective cohort The results
Strengths:
To examine the
study of all singleton
included 6468
Large number of women
associations
deliveries born over 20 women, 6107
included in the analysis
between
weeks.
nonusers and 361
and the ability to control
marijuana use and Evaluating various
marijuana users.
the confounding medical
obstetrical and neonatal After adjustment
certain adverse
and social factors, such
obstetrical and
outcomes including
for maternal age,
as race, obesity and lack
neonatal
preterm delivery, prerace, parity, body
of adequate prenatal care.
outcomes,
eclampsia, gestational
mass index and no In addition, maternal
excluding women diabetes, cesarean
prenatal care, we
exposure data were taken
delivery, fetal growth
with
found higher rates
directly from the medical
polysubstance use restriction, a composite of small for
record and based upon a
and stratifying for which included
gestational age and combination of selfcoexisting tobacco stillbirth or neonatal
neonatal intensive
report and toxicology
intensive care unit
use
care unit admission screen results and may be
admission, and
in women who
more accurate as opposed
perinatal mortality.
were not tobacco
to reliance on selfreporting in birth
Stratified study groups users. Other
obstetrical
certificate records.
according to the
maternal tobacco use
outcomes including
and performed a
preterm delivery
Sample/Setting:
and fetal anomalies
logistic regression
Included in this
were not increased
analysis.
study were 6468
with maternal
women, 6107
marijuana use
nonusers and 361
marijuana users at
the University of
Limitations:
Cincinnati
Not designed to
Medical Center
determine dose-related
between January
effects. The setting is a
2008 and January
high-risk academic center
2011.
Conclusion:
with a large referral base,
Maternal
and as such the rates of
marijuana use does exposures and outcomes
not increase the
may vary from other
risk of adverse
regions. Does not have
obstetrical
enough power to draw
outcomes or fetal
conclusions for all the
anomalies but does outcome variables
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Johns Hopkins
Evidence
Appraisal:
Strength
III

increase the risk for studied, including
small for
perinatal mortality.
gestational age and
neonatal intensive
care unit
admission.

Quality:
High, large
population

Author Recommendations:
Further study of the complications of marijuana exposure in pregnancy, especially as political
and social changes evolve that could increase the rate of this exposure in pregnant women.
Summary for current clinical practice question:
A good understanding of the risks to marijuana use in pregnancy is needed so providers can
educate women who are planning to become pregnant or who are pregnant.

